This is a demo store. No orders will be fulfilled.

Life Sciences

Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas

The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.

Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.

The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.

We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.

We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.

  1. 20 Mar 2019  |  North America  |  Mega Trends

    Growth Opportunities in the North American Clinical Laboratory Services Market, Forecast to 2022

    Laboratories Seek Alternate Revenue Streams to Combat Reimbursement Pressure

    Clinical laboratory services represent one of the highest healthcare expenditures in North America, yet the United States and Canada represent different scenarios in the way clinical services are rendered. The market for clinical lab services in Canada was an estimated $10.33 billion in 2017 whereas in the United States it was an estimated $78.33 b...

    $4,950.00
  2. 14 Jan 2019  |  North America  |  Mega Trends

    Growth Opportunities in the Global qPCR and dPCR Market, Forecast to 2023

    Novel Applications in Oncology and Applied Sciences, Growing Research and Diagnostic Use in Developing Regions, and Automated Modular Workflows to Drive Growth

    Overview: PCR continues to be the gold standard for nucleic acid amplification by combining accuracy and efficacy that users across areas such as research, pharma & biotech, diagnostics as well as applied sciences depend upon. Such widespread usage continues to drive the industry, even protecting it to some extent from overall economic/market fluct...

    $4,950.00
  3. 12 Dec 2018  |  North America  |  Mega Trends

    Growth Opportunities in Functional Consumables Aftermarket, Forecast to 2023

    Innovation-as-a-service Business Model will Accelerate Growth in the Molecular Diagnostic Subsegment

    Rapid technological turnaround has become a norm in the life science and in-vitro diagnostic industry. Extrinsic factors such as lack of skilled labor to operate the instrumentation as well as functional factors like demand for very high precision and reproducibility of results are driving this technological evolution. As the instrument efficiency ...

    $4,950.00
  4. 24 Oct 2018  |  North America  |  Mega Trends

    Growth Opportunities in the Global Cell Therapy Market, Forecast to 2025

    A Robust Product Pipeline Creating Opportunities for Ground-breaking Combination Therapies is Set to Revolutionize the Global Cell Therapy Market

    The global pharmaceuticals industry is continuously evolving to meet the requirements of a changing disease landscape. With the increasing prevalence of chronic infectious diseases and cancer, market needs are shifting from traditional small molecules to novel large molecule therapies, with cell therapies dominating the space. This study presents a...

    $4,950.00
  5. 09 Apr 2018  |  North America  |  Market Outlook

    Global Life Sciences Industry Outlook, 2018

    Global Life Sciences Industry to Reach $1.5 T by 2022, Driven by Innovative Google, Amazon, Facebook, Apple (GAFA) Partnerships and R&D IT Investments

    The global life sciences industry is onto a rocking start with the surge in CEO confidence from US tax reforms, rollicking equity markets and strengthening the global economy. Healthcare digitization, democratization creating explosion in patient data, emergence of value-based reimbursement models, and healthcare consumerism shifting the risk from ...

    $4,950.00
  6. 27 Nov 2017  |  North America  |  Mega Trends

    Growth Opportunities in the Global Digital Pathology Market, Forecast to 2021

    New Business Models and More FDA Approvals of WSI Scanners for Primary Diagnostics are Set to Boost Growth of Digital Pathology

    Shortage of pathologists and the rise in new cancer cases are the key drivers for the adoption of digital pathology solutions globally. Digital pathology enhances the productivity of pathologists by 10% to 15%, thereby improving the overall efficiency of healthcare providers. Digital pathology solutions find the best fit in oncology care. Accordin...

    $4,950.00
  7. 23 May 2017  |  North America  |  Mega Trends

    Growth Opportunities in the US In Vitro Diagnostics (IVD) Market, Forecast to 2021

    US IVD Market Witnesses Pricing Fluctuations Due to the PAMA Regulation

    The In Vitro Diagnostics (IVD) landscape in the United States is extremely dynamic, with a high level of merger and acquisition activity with many high-value deals still pending. Both clinical laboratories and manufacturers are increasingly vying for smaller specialized niche technology companies to increase their market share. Molecular point of c...

    $4,950.00
  8. 09 Jan 2017  |  North America  |  Customer Research

    2016 Global Survey on Clinical Next-Generation Sequencing

    Respondents Show Vivid Interest in Developing Clinical NGS-based Tests for Infectious Disease Testing Applications

    The primary goal of this research is to analyze the current and future adoption plans of Next-Generation Sequencing (NGS) for clinical applications. The survey seeks to collect the following key information: • Outsourcing needs and clinical NGS service providers • Current and future interest areas of clinical NGS • Genetic elements of in...

    $4,950.00
  9. 16 Feb 2015  |  North America  |  Customer Research

    Global Survey on Laboratory Information Management Systems

    An End-user Perspective

    Laboratory personnel were invited to participate in an online survey in June 2014. A total of 366 laboratory decision makers qualified to complete the survey, answering questions about their use of laboratory information management systems (LIMS). Respondents organization types include academic laboratory or core facility; federal, state, or local...

    $6,950.00
  10. 30 Dec 2014  |  North America  |  Customer Research

    2015 Global Laboratory Products Purchasing Trends

    End-user Perspective

    Readers of the Lab Manager Magazine were invited to participate in an online survey in September 2014. To qualify for survey participation, readers were required to play a role in their laboratory’s purchasing process, be familiar with their laboratories’ product budgets, and represent a laboratory that either uses or plans to use products in o...

    $6,950.00